Skip to main content

What the FDA labels say about taking them together

Lidocaine and ritonavir

Ritonavir's FDA label of July 23, 2026 names lidocaine in its drug interactions section; the lidocaine labels PlainMeds reads (4) do not name ritonavir. The ritonavir label: “Caution is warranted and therapeutic concentration monitoring is recommended for antiarrhythmics when co-administered with ritonavir, if available.”

Check it at the source: the lidocaine FDA label on DailyMed (effective May 13, 2024, Fresenius Kabi USA, LLC); the ritonavir FDA label on DailyMed (effective July 23, 2026, AbbVie Inc.).

What does the lidocaine label say about ritonavir?

Lidocaine's label (effective May 13, 2024) and its 3 other brand-application labels do not name ritonavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Xylocaine MPF), Fresenius Kabi USA, LLC, effective May 13, 2024 (SPL set d5e0d06f-ba1e-44d4-aa89-39d6c146dc23), via openFDA; the full label on DailyMed

What does the ritonavir label say about lidocaine?

Ritonavir label, drug interactions

Concomitant Drug Class/Drug Name: Antiarrhythmics: disopyramide, lidocaine, mexiletine; Effect on Concentration of Ritonavir or Concomitant Drug: ↑ antiarrhythmics; Clinical Comment: Caution is warranted and therapeutic concentration monitoring is recommended for antiarrhythmics when co-administered with ritonavir, if available.

Source: FDA drug label (Norvir), AbbVie Inc., effective July 23, 2026 (SPL set 2849298e-de6e-47bb-8194-56e075b33fc3), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

81Lidocaine generic labelers
7Ritonavir generic labelers
LidocaineRitonavir
Labeled forPainHIV
Boxed warningNoYes
Pharmacy cost (NADAC)$0.154 per gram 5% ointment$0.607 per tablet 100 mg tablet
Shortage nowIn shortageA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?